The role of estrogen receptors (ERs) in breast cancer is of great importance in both clinical
practice and scientific exploration. However, around 15–30% of those affected do not see …

Estrogen‐related receptor α (ERRα) is considered a very promising target for treating
metabolic diseases such as type 2 diabetes. Development of a prediction model to quickly …

Understanding breast cancer drug response mechanisms can play a crucial role in
improving treatment outcomes and survival rates. Existing bioinformatics-based approaches …

Estrogen receptor α (ERα) is a successful target for ER‐positive breast cancer and also
reported to be relevant in many other diseases. Selective estrogen receptor modulators …

Background Estrogen receptors (ERs) are nuclear transcription factors that are involved in
the regulation of many complex physiological processes in humans. ERs have been …

Estrogen receptor (ER)-α has long been a potential target in ER-α-positive breast cancer
therapeutics. In this study, we integrated ER-α-related bioinformatic data at different levels to …

Estrogen receptor α (ERα) and estrogen receptor β (ERβ) regulate different sets of gene
expression, and have different ligand responses, which make the estrogen tissue-specific …

By predicting ERα bioactivity and mining the potential relationship between Absorption,
Distribution, Metabolism, Excretion, Toxicity (ADMET) attributes in drug research and …

Breast cancer, the second most prevalent cancer among women worldwide, necessitates
the exploration of novel therapeutic approaches. To target the four subgroups of breast …

Progesterone receptors (PRs) are implicated in various cancers since their
presence/absence can determine clinical outcomes. The overstimulation of progesterone …